Correlation Between Intel and Avalo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intel and Avalo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intel and Avalo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intel and Avalo Therapeutics, you can compare the effects of market volatilities on Intel and Avalo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intel with a short position of Avalo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intel and Avalo Therapeutics.

Diversification Opportunities for Intel and Avalo Therapeutics

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Intel and Avalo is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Intel and Avalo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avalo Therapeutics and Intel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intel are associated (or correlated) with Avalo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avalo Therapeutics has no effect on the direction of Intel i.e., Intel and Avalo Therapeutics go up and down completely randomly.

Pair Corralation between Intel and Avalo Therapeutics

Given the investment horizon of 90 days Intel is expected to generate 0.79 times more return on investment than Avalo Therapeutics. However, Intel is 1.27 times less risky than Avalo Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Avalo Therapeutics is currently generating about -0.34 per unit of risk. If you would invest  2,290  in Intel on August 30, 2024 and sell it today you would earn a total of  75.00  from holding Intel or generate 3.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Intel  vs.  Avalo Therapeutics

 Performance 
       Timeline  
Intel 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Intel are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Intel may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Avalo Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Avalo Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Avalo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Intel and Avalo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Intel and Avalo Therapeutics

The main advantage of trading using opposite Intel and Avalo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intel position performs unexpectedly, Avalo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avalo Therapeutics will offset losses from the drop in Avalo Therapeutics' long position.
The idea behind Intel and Avalo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments